Mon panier

Granzyme B

Granzyme B Liste de produits

  • Attribut

    Kits (2)Protein (1)

  • Bibliothèque de produits

    En ligne (2)En recherche (1)

  • Espèces

    Human (3)

  • Étiquette

    - (2)Tag Free (1)

  • Marqueur

    - (2)Unconjugated (1)

Numéro de produitEspècesSystème d'expressionDescription du produitStructure protéiquePuretéCaractéristiquesPré-commande/Commande
Human
-
Human Granzyme B ELISA Kit Ajouter au panier
Human
-
Human Granzyme B Detection Kit (Flow Cytometry Bead Assay) Précommande
Human
HEK293
Human Granzyme B Protein, Tag Free (active enzyme)
Ajouter au panier
Quantité totale3
  • 1

Granzyme BContexte de la molécule

Granzyme B (GZMB) is also known as Cathepsin G-like 1 (CTSGL1), Cytotoxic T-lymphocyte proteinase 2 (Lymphocyte protease), Fragmentin-2, Granzyme-2, Human lymphocyte protein (HLP), SECT, CGL1, CSPB, CTLA1, GRB, which belongs to the peptidase S1 family. Granzyme subfamily. GZMB / CTSGL1 contains 1 peptidase S1 domain. The catalytic activity of Granzyme B is “Preferential cleavage: -Asp-|-Xaa- >> -Asn-|-Xaa- > -Met-|-Xaa-, -Ser-|-Xaa-“, and is Inactivated by the serine protease inhibitor diisopropyl fluorophosphates. GZMB is necessary for target cell lysis in cell-mediated immune responses. It cleaves after Asp. GZMB seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution and cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
DR-01DR-01Phase 2 ClinicalDren Bio IncLeukemia; Enteropathy-Associated T-Cell Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma; Lymphoma, T-Cell; Bacterial Infections; Autoimmune Diseases of the Nervous System; Leukemia, Large Granular Lymphocytic
Details
  • Liste de produits
  • Informations sur les médicaments cliniques